Full mechanism, in text

Plaque cascade

1 · Endothelial injury

Hypertension, hyperglycemia, smoke and oxidative stress repeatedly injure the endothelium so it makes less , and this endothelial dysfunction comes before rising and plaque.Atherosclerosis is not a one-off event — it is decades of chronic inflammation.

Starting point: chronic hypertension / hyperglycemia / smoke / oxidative stress repeatedly punctures the endothelium's tolerance. The earliest reversible marker: production ↓ → 'endothelial dysfunction'. This step is earlier than rising , earlier than plaque, earlier than any symptom.

· Smokers: smoke oxidants quench NO, so less NO is available at the endothelium
· Diabetics: chronic hyperglycemia uncouples eNOS, producing less NO than baseline
· Persistent hypertension: the endothelium is repeatedly torn by shear stress, permeability rises, the intima becomes structurally loose.

Key sentence: the endothelium is not 'plastered over' — it is slowly poked through. Anything that protects the endothelium (quitting smoking / glucose control / blood-pressure control / exercise) is blocking Step 1; the earlier the larger the benefit.

2 · sdLDL infiltration + oxidation

Small dense crosses the injured endothelium and is oxidized beneath the intima into ox-LDL, the antigen the immune system treats as a foreign threat.Small dense LDL particles (sdLDL) cross the injured endothelium, and beneath the intima are oxidized by free radicals → ox-LDL. This is the real antigen the immune system sees as a 'foreign threat' — not ordinary .

· The smaller the LDL particle, the more atherogenic — large LDL behaves well; sdLDL is the real culprit
· is a more accurate marker: each atherogenic particle carries one ApoB-100, so counting particles is more accurate than measuring cholesterol (ordinary LDL-C underestimates risk when sdLDL fraction is high)
· is a special particle ('LDL with an outer coat'); 90% determined by the LPA gene, almost unaffected by diet / statins — testing once in a lifetime is enough.

Statins act precisely at this step: lowering LDL 30-50% = fewer ApoB particles entering the vessel wall = reduced Step 2 input.

3 · Foam cell formation

Monocytes enter the intima and become macrophages that keep swallowing ox-LDL through scavenger receptors with no negative feedback, bloating into foam cells that die and recruit more.The endothelium expresses VCAM-1 / ICAM-1 adhesion molecules → monocytes adhere → enter the intima and differentiate into macrophages → via scavenger receptors (CD36 + SR-A) they ingest huge amounts of ox-LDL.

The key trap: the scavenger-receptor pathway has no negative feedback — unlike the low-density lipoprotein () receptor, it does not downregulate. Macrophages bloat into 'foam cells' until they die; when they die, the internal ox-LDL is released again, recruiting more macrophages.

· Scavenger receptors have no negative feedback, so the foam-cell loop accelerates itself. That is not a law that plaques can never shrink: fatty streaks (next step) can still regress, and later plaque volume can fall when LDL is lowered hard
· High glucose + high insulin + chronic inflammation make this loop run faster
· / act at this step in 'inflammation resolution (resolvin / protectin)' — this is how omega-3s can reduce cardiovascular events without lowering LDL.

4 · Fatty streak — already in childhood

Foam cells and extracellular lipid build up into visible fatty streaks, already present in childhood, and this step is still reversible.Foam cells + extracellular lipid accumulation form visible yellow streaks — present in childhood, found in almost every adolescent autopsy. This step is still reversible: endothelial recovery + reduced input → existing fatty streaks can regress, with macrophages carrying lipids back to the liver.

Why this is the most important step in the whole process:

· 'Cardiovascular disease is an old-age disease' is wrong — pathological changes begin before age 30
· Intervention at 30-40 ≫ intervention at 50-60; early streaks can vanish, and later plaque volume can still fall when LDL is cut hard, but the fibrous cap and calcium rarely disappear
· This is also the anatomical root of long-term cardiovascular risk from 'childhood obesity + high-sugar diet'.

Clinical warning: don't wait for an abnormal lipid panel before acting — a normal lipid panel doesn't mean clean vessels, it just means Step 2 input hasn't yet pushed Step 4 to the next stage.

5 · Fibrous plaque + calcification

Vascular smooth muscle cells migrate into the intima and secrete collagen to form a fibrous cap over the lipid core, calcium deposits, and the plaque starts to narrow the vessel.Vascular smooth muscle cells (VSMC) migrate from the media to the intima and secrete collagen + elastin, forming a fibrous cap that covers the lipid core. Calcium begins to deposit — this is exactly what the CT calcium score (CAC score) measures.

· The plaque begins to narrow the vessel → angina / intermittent claudication / transient ischemic attacks appear
· CAC > 100 = significant calcification; > 400 = high risk
· Calcification itself is the body's effort to 'reinforce the plaque', which is actually more stable than soft lipid plaque — but it shows the process, from oxidized low-density lipoprotein () to a formed plaque, has already gone a long way.

Do 'statins worsen plaque calcification'? On the surface, yes — statins reduce the lipid core, and the residual calcification fraction rises, but absolute event rate falls — this is 'soft plaque hardening' stabilization, not disease progression. For statin users, watch the rate of change of CAC score rather than the absolute value.

6 · Plaque rupture → thrombus → MI

A heart attack is not a vessel filling up but a fibrous cap suddenly rupturing, often on a moderately stenotic vulnerable plaque, after which an acute thrombus fills the lumen.Key turning point: a heart attack is not 'the vessel completely filling up' — it is 'the fibrous cap suddenly rupturing' — often a moderately stenotic (40-70%) 'vulnerable plaque' rather than the severely stenotic one.

The moment of rupture (seconds):

· Lipid core exposed to blood flow
· Platelets aggregate instantly (von Willebrand factor + collagen recognition)
· Coagulation cascade activated → thrombin → fibrin mesh
· Acute thrombus fills the lumen → distal myocardial ischemia → myocardial infarction.

Heart attacks cluster from 6 am to noon (Muller 1985 NEJM): at the moment of waking, sympathetic activation + sharp BP rise + peak platelet activity → vulnerable plaque ruptures. This is the mechanistic explanation for 'why morning cardiovascular events are more frequent'.

Interventions at this step:

· Aspirin (low dose) → platelet inhibition, reduces post-rupture thrombus growth → reduces mortality
· Statins → stabilize the fibrous cap + anti-inflammatory + anti-rupture; plaque stability rises even when doesn't fall much
· Quitting smoking → acutely reduces sympathetic activation + reduces platelets.

Conclusion: only by seeing this chain clearly can you understand which exact step each intervention is blocking.

Full mechanism, in text

1 · Endothelial injury

2 · sdLDL infiltration + oxidation

3 · Foam cell formation

4 · Fatty streak — already in childhood

5 · Fibrous plaque + calcification

6 · Plaque rupture → thrombus → MI

Atherosclerosis · the 6-step cascade

Full mechanism, in text

1 · Endothelial injury

2 · sdLDL infiltration + oxidation

3 · Foam cell formation

4 · Fatty streak — already in childhood

5 · Fibrous plaque + calcification

6 · Plaque rupture → thrombus → MI

Atherosclerosis · the 6-step cascade